Delaware
|
000-54402
|
91-1835664
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File No.)
|
(IRS Employer Identification Number)
|
40 Marcus Drive, Melville, New York
|
11747
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
____
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
____
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
____
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
____
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01.
|
Entry into Material Definitive Agreement.
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
10.1 |
Employment Agreement, dated as of October 15, 2018, by and between BioRestorative Therapies, Inc. and Lance Alstodt
|
10.2 |
Stock Option Agreement, dated as of October 15, 2018, by and between BioRestorative Therapies, Inc. and Lance Alstodt
|
BIORESTORATIVE THERAPIES, INC. | |||
Dated: October 17, 2018
|
By:
|
/s/ Mark Weinreb | |
Mark Weinreb | |||
Chief Executive Officer | |||